RNASEH1

Ribonuclease H1 · O60930 · RNASEH1 on Sugi Atlas →

3,123 patent compounds predicted against RNASEH1, 2,013 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours
SCHEMBL37942 SCHEMBL37942 0.45 3/20
SCHEMBL1553610 SCHEMBL1553610 0.44 3/20
SCHEMBL38005 SCHEMBL38005 0.42 3/20
SCHEMBL38178 SCHEMBL38178 0.42 3/20
SCHEMBL891835 SCHEMBL891835 0.39 3/20
SCHEMBL6357709 SCHEMBL6357709 0.60 2/20
SCHEMBL405399 SCHEMBL405399 0.60 2/20
SCHEMBL405327 SCHEMBL405327 0.56 2/20
SCHEMBL405533 SCHEMBL405533 0.56 2/20
SCHEMBL405606 SCHEMBL405606 0.56 2/20
SCHEMBL5677631 SCHEMBL5677631 0.55 2/20
SCHEMBL259477 SCHEMBL259477 0.55 2/20
SCHEMBL400090 SCHEMBL400090 0.54 2/20
SCHEMBL37513 SCHEMBL37513 0.53 2/20
SCHEMBL3494163 SCHEMBL3494163 0.53 2/20
SCHEMBL6594881 SCHEMBL6594881 0.52 2/20
SCHEMBL456753 SCHEMBL456753 0.51 2/20
SCHEMBL6619853 SCHEMBL6619853 0.51 2/20
SCHEMBL6620304 SCHEMBL6620304 0.51 2/20
SCHEMBL6593358 SCHEMBL6593358 0.49 2/20

Clinical trials — most relevant to RNASEH1 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Long Term Extension Study in Patients With Primary Hyperoxaluria PHASE3ACTIVE_NOT_RECRUITING
Reverse Transcriptase Inhibitors in AGS PHASE2COMPLETED
Clinical Study of EBV-LMP1 Targeted DNAzyme to Treat Nasopharyngeal Carcinoma PHASE1/PHASE2COMPLETED
Safety and Efficacy Study of ISIS 301012 (Mipomersen) Administration in High Risk Statin Intolerant Subjects PHASE2COMPLETED
Phase 1b Safety Study of IMSB301 in Type 1 Interferonopathies PHASE1RECRUITING
Clinical Manifestations and Biomarkers in Amyotrophic Lateral Sclerosis Type 4 and Other Inherited Neurological Disorders of RNA Processing nanRECRUITING
Diagnosis of Inflammatory Bowel Disease nanNOT_YET_RECRUITING
Expression Pattern of HNRNPH1 and HNRNPK Genes in MPNs nanUNKNOWN
LINC00511/miR-185-3p Axis and miR-301a-3p Markers for Breast Cancer Diagnosis nanCOMPLETED
International PPB/DICER1 Registry nanRECRUITING
NFC Changes in SLE Patients and Its Correlation With Anti-U1RNPAntibodies and Disease Activity nanUNKNOWN
X-chromosome Inactivation, Epigenetics and the Transcriptome nanCOMPLETED
MiRNA223 and HMGB1 as Apredictos for Drug Resistant Epilepsy nanUNKNOWN
The Value of circRNAs (hsa_circ_0004001) in Early Diagnosis of HCC nanUNKNOWN
Whole-genome Sequencing Study in Patients With Diminished Ovarian Reserve nanUNKNOWN
Liquid Biopsy for Early Detection of Colorectal Cancer Using Circular RNA nanRECRUITING
Genetic Investigation of Cancer Predisposition nanNOT_YET_RECRUITING
PCD New Gene Discovery nanCOMPLETED
Screening of Lysosomal Storage Disorders Diseases in Minority Groups nanUNKNOWN
DICER1-related Pleuropulmonary Blastoma Cancer Predisposition Syndrome: A Natural History Study nanRECRUITING
Evaluation of a ddPCR Technology for the SARS-CoV-2 Detection in Symptomatic Patients With Suspicion of COVID-19 nanCOMPLETED
Impact of Weight Loss on the Human Sperm Epitranscriptome nanACTIVE_NOT_RECRUITING
Identifying Genes and Mutations Underlying Retinitis Pigmentosa and Allied Diseases nanUNKNOWN
Study of Specimens From Young Patients With Neuroblastoma nanCOMPLETED
Biomarkers in Patients With Diffuse Large B-Cell Lymphoma Treated With Combination Chemotherapy With or Without Rituximab nanCOMPLETED
Clinical Genetics Branch Eligibility Screening Survey nanNOT_YET_RECRUITING
Longitudinal Study of Neurogenetic Disorders nanRECRUITING
A Prospective, Multicenter, Collaborative Study to Determine the Prevalence of Nontuberculous Mycobacteria (NTM) in Pediatric Patients With Cystic Fibrosis in Florida nanCOMPLETED
Role of Genetic Factors in the Development of Lung Disease nanRECRUITING
Diagnosis and Phenotype Characterisation Using Genomics in Patients With Inherited Bone Marrow Failure (IBMDx Study) nanRECRUITING

Related proteins — ESM-2 sequence neighbours (a RNASEH1 binder may also engage these)

ProteinNameSimilarity
O70338 1.000 O70338 →
Q5BK46 1.000 Q5BK46 →
Q754C9 0.983 Q754C9 →
O70157 0.981 O70157 →
Q9H0M0 0.978 Q9H0M0 →
P39867 0.978 P39867 →
Q9UST8 0.978 Q9UST8 →
Q75LI2 0.978 Q75LI2 →
P27967 0.978 P27967 →
Q8LPU5 0.977 Q8LPU5 →
Q5R6G3 0.977 Q5R6G3 →
O60231 0.977 O60231 →
Q9AWM8 0.977 Q9AWM8 →
P25799 0.977 P25799 →
Q9S7G6 0.977 Q9S7G6 →
Q8LQJ8 0.976 Q8LQJ8 →
B4GEU1 0.976 B4GEU1 →
Q2VF18 0.976 Q2VF18 →
KDM5D Lysine-specific demethylase 5D 0.976 landscape →
A4RHU9 0.976 A4RHU9 →
P27783 0.976 P27783 →
A4RKC3 0.976 A4RKC3 →
Q9LVM5 0.976 Q9LVM5 →
Q9ARI6 0.976 Q9ARI6 →
Q8LI34 0.976 Q8LI34 →
B2ZFP3 0.976 B2ZFP3 →
Q9SS38 0.976 Q9SS38 →
Q5JKF2 0.976 Q5JKF2 →
Q62940 0.976 Q62940 →
Q9ZSV1 0.976 Q9ZSV1 →